Filing Flows › Incyte (INCY) › How it makes money
How Incyte (INCY) makes money
Incyte (INCY) made $1.6B of revenue in the third quarter 2026 (Q3 2026), +14% from a year earlier. Net sales brought in $1.3B (85%); NIKTIMVO brought in $67.4M (4%); ZYNYZ brought in $58.3M (4%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Net sales | $1.3B | 84.7% | — | +11% |
| ↳ JAKAFI | $827M | 53.1% | — | +4% |
| ↳ OPZELURA | $255M | 16.4% | — | +36% |
| ↳ JAKAVI | $132M | 8.5% | — | +5% |
| ↳ MINJUVI/MONJUVI | $54.6M | 3.5% | — | +30% |
| ↳ Milestone and contract revenues | $49.8M | 3.2% | — | +11% |
| NIKTIMVO | $67.4M | 4.3% | — | +47% |
| ZYNYZ | $58.3M | 3.7% | — | +157% |
| OLUMIANT | $39.1M | 2.5% | — | +5% |
| ICLUSIG | $33.5M | 2.2% | — | -11% |
| PEMAZYRE | $21.2M | 1.4% | — | -7% |
| Other | $12.6M | 0.8% | — | +582% |
| TABRECTA | $6.8M | 0.4% | — | +5% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $1.6B | 100.0% |
| Income tax | $96.0M | 6.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $1.6B | +14% |
| Q2 2026 | $1.7B | +38% |
| Q1 2026 | $1.3B | +21% |
| Q4 2025 | $1.5B | +28% |
| Q3 2025 | $1.4B | +20% |
| Q2 2025 | $1.2B | +16% |
| Q1 2025 | $1.1B | +20% |
From Incyte's 10-Q filed Oct 29, 2026 (on EDGAR).
Questions
How does Incyte make money?
Incyte (INCY) made $1.6B of revenue in the third quarter 2026 (Q3 2026), +14% from a year earlier. Net sales brought in $1.3B (85%); NIKTIMVO brought in $67.4M (4%); ZYNYZ brought in $58.3M (4%).
What is Incyte's biggest business?
Net sales: $1.3B in the third quarter 2026, 85% of revenue, +11% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.